tradingkey.logo


tradingkey.logo


CVS Health Corp

CVS
72.800USD
+1.510+2.12%
āļ›āļīāļ” 03/24, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
93.91BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
52.17P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ CVS Health Corp āļšāļĢāļīāļĐāļąāļ—

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

āļ‚āđ‰āļ­āļĄāļđāļĨ CVS Health Corp


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™CVS
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—CVS Health Corp
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 06, 2088
āļ‹āļĩāļ­āļĩāđ‚āļ­Joyner (J. David David)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™300000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Nov 06
āļ—āļĩāđˆāļ­āļĒāļđāđˆOne Cvs Dr.
āđ€āļĄāļ·āļ­āļ‡WOONSOCKET
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ02895
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ14017651500
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://cvshealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™CVS
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļNov 06, 2088
āļ‹āļĩāļ­āļĩāđ‚āļ­Joyner (J. David David)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ CVS Health Corp


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-16.19%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+12.09%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
5.93K
+27.86%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+27.86%
Mr. Roger N. Farah
Mr. Roger N. Farah
Director
Director
4.12K
-1215.45%
Mr. C. David Brown, II
Mr. C. David Brown, II
Independent Director
Independent Director
--
--
Ms. Anne M. Finucane
Ms. Anne M. Finucane
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-16.19%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+12.09%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
5.93K
+27.86%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pharmacy
59.55B
57.89%
Premiums
33.72B
32.78%
Front Store
5.19B
5.05%
Other
3.78B
3.67%
Net investment income(loss)
632.00M
0.61%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pharmacy
59.55B
57.89%
Premiums
33.72B
32.78%
Front Store
5.19B
5.05%
Other
3.78B
3.67%
Net investment income(loss)
632.00M
0.61%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
9.44%
Capital World Investors
5.32%
BlackRock Institutional Trust Company, N.A.
5.11%
Dodge & Cox
4.91%
State Street Investment Management (US)
4.73%
āļ­āļ·āđˆāļ™ āđ†
70.49%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
9.44%
Capital World Investors
5.32%
BlackRock Institutional Trust Company, N.A.
5.11%
Dodge & Cox
4.91%
State Street Investment Management (US)
4.73%
āļ­āļ·āđˆāļ™ āđ†
70.49%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
47.30%
Investment Advisor/Hedge Fund
30.90%
Hedge Fund
3.67%
Research Firm
2.83%
Pension Fund
2.20%
Bank and Trust
1.97%
Sovereign Wealth Fund
1.76%
Individual Investor
1.04%
Insurance Company
0.09%
āļ­āļ·āđˆāļ™ āđ†
8.24%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
3559
1.14B
91.37%
+184.05K
2025Q3
3681
1.14B
91.69%
+21.03M
2025Q2
3720
1.12B
91.24%
+11.94M
2025Q1
3762
1.11B
87.65%
+493.45K
2024Q4
3844
1.07B
85.40%
+28.70M
2024Q3
3797
1.04B
85.89%
-7.86M
2024Q2
3821
1.05B
84.06%
+19.75M
2024Q1
3841
1.03B
84.50%
-33.86M
2023Q4
3855
1.05B
81.50%
+16.24M
2023Q3
3736
1.03B
81.41%
+4.51M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
118.25M
9.31%
-1.53M
-1.28%
Sep 30, 2025
Capital World Investors
68.38M
5.39%
+1.42M
+2.12%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
64.32M
5.07%
+761.36K
+1.20%
Sep 30, 2025
Dodge & Cox
73.18M
5.76%
-112.18K
-0.15%
Sep 30, 2025
State Street Investment Management (US)
58.94M
4.64%
+149.70K
+0.25%
Sep 30, 2025
Fidelity Management & Research Company LLC
35.39M
2.79%
-2.20M
-5.85%
Sep 30, 2025
Geode Capital Management, L.L.C.
28.99M
2.28%
+352.53K
+1.23%
Sep 30, 2025
Capital International Investors
26.69M
2.1%
+302.50K
+1.15%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
19.70M
1.55%
+994.06K
+5.31%
Jun 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
iShares U.S. Healthcare Providers ETF
12.05%
Invesco S&P Ultra Dividend Revenue ETF
6.26%
Coastal Compass 100 ETF
5.67%
Davis Select US Equity ETF
5.6%
Simplify Health Care ETF
5.48%
VanEck Retail ETF
4.53%
iShares US Consumer Staples ETF
4.18%
Invesco S&P 500 Pure Value ETF
3.71%
Invesco S&P 500 Enhanced Value ETF
3.03%
JPMorgan Healthcare Leaders ETF
2.99%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
iShares U.S. Healthcare Providers ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™12.05%
Invesco S&P Ultra Dividend Revenue ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™6.26%
Coastal Compass 100 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.67%
Davis Select US Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.6%
Simplify Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™5.48%
VanEck Retail ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.53%
iShares US Consumer Staples ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.18%
Invesco S&P 500 Pure Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.71%
Invesco S&P 500 Enhanced Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.03%
JPMorgan Healthcare Leaders ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.99%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 12.04B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Jan 06, 2026
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 02, 2026 going ex on Jan 22, 2026
Jan 22, 2026
Feb 02, 2026
Jan 22, 2026
Sep 17, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 03, 2025 going ex on Oct 23, 2025
Oct 23, 2025
Nov 03, 2025
Oct 23, 2025
Jul 07, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2025 going ex on Jul 22, 2025
Jul 22, 2025
Aug 01, 2025
Jul 22, 2025
Mar 20, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2025 going ex on Apr 22, 2025
Apr 22, 2025
May 01, 2025
Apr 22, 2025
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™